A critique of the second consensus criteria for multiple system atrophy

Iva Stankovic, MD, Niall Quinn, MD, Luca Vignatelli, MD, Angelo Antonini, MD, Daniela Berg, MD, PhD, Elizabeth Coon, MD, Pietro Cortelli, MD, Alessandra Fanciulli, MD, PhD, Joaquim J. Ferreira, MD, PhD, Roy Freeman, MD, Glenda Halliday, MD, Günter U. Höglinger, MD, Valeria Iodice, MD, Horacio Kaufmann, MD, Thomas Klockgether, MD, Vladimir Kostic, MD, PhD, Florian Krismer, MD, PhD, Anthony Lang, MD, Johannes Levin, MD, Phillip Low, MD, Christopher Mathias, MD, Wassillios G. Meissner, MD, PhD, Lucy Norcliffe Kaufmann, PhD, Jose-Alberto Palma, MD, PhD, Jalesh N. Panicker, MD, FRCP, Maria Teresa Pellecchia, MD, PhD, Ryuji Sakakibara, MD, PhD, Jeremy Schmahmann, MD, Sonja W. Scholz, MD, PhD, Wolfgang Singer, MD, Maria Stamelou, MD, PhD, Eduardo Tolosa, MD, Shoji Tsuji, MD,PhD, Klaus Seppi, MD, PhD, Werner Poewe, MD, and Gregor K. Wenning, MD, PhD,* on behalf of the Movement Disorder Society Multiple System Atrophy Study Group

[1]  J. Volkmann,et al.  Young‐onset multiple system atrophy: Clinical and pathological features , 2018, Movement disorders : official journal of the Movement Disorder Society.

[2]  W. Poewe,et al.  Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis , 2017, PloS one.

[3]  Gerta Rücker,et al.  18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment , 2017, The Journal of Nuclear Medicine.

[4]  E. Benarroch,et al.  Pure autonomic failure , 2017, Neurology.

[5]  D. Dickson,et al.  Profile of cognitive impairment and underlying pathology in multiple system atrophy , 2017, Movement disorders : official journal of the Movement Disorder Society.

[6]  R. Freeman,et al.  Natural history of pure autonomic failure: A United States prospective cohort , 2017, Annals of neurology.

[7]  W. Poewe,et al.  Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism , 2016, Neurology.

[8]  D. Hernandez,et al.  Genome-wide estimate of the heritability of Multiple System Atrophy. , 2016, Parkinsonism & related disorders.

[9]  R. Freeman,et al.  Clinical implications of delayed orthostatic hypotension , 2015, Neurology.

[10]  G. Deuschl,et al.  MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.

[11]  D. Dickson,et al.  When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.

[12]  J. Jankovic,et al.  Natural History of Multiple System Atrophy in North America: A Prospective Cohort Study , 2015, The Lancet Neurology.

[13]  W. Poewe,et al.  New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  D. Dickson,et al.  Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein , 2015, Acta Neuropathologica.

[15]  A. Lang,et al.  MRI signs of multiple system atrophy preceding the clinical diagnosis: the case for an imaging-supported probable MSA diagnostic category , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  W. Poewe,et al.  Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.

[17]  N. Quinn,et al.  Markedly asymmetric presentation in multiple system atrophy. , 2013, Parkinsonism & related disorders.

[18]  N. Quinn,et al.  “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.

[19]  Günther Deuschl,et al.  The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.

[20]  J. Trojanowski,et al.  Mutations in COQ2 in familial and sporadic multiple-system atrophy. , 2013, The New England journal of medicine.

[21]  Nick C Fox,et al.  Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.

[22]  L. Hazrati,et al.  Multiple system atrophy–parkinsonism with slow progression and prolonged survival: A diagnostic catch , 2012, Movement disorders : official journal of the Movement Disorder Society.

[23]  S. Orimo,et al.  123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. , 2012, Parkinsonism & related disorders.

[24]  N. Quinn,et al.  A validation exercise on the new consensus criteria for multiple system atrophy , 2009, Movement disorders : official journal of the Movement Disorder Society.

[25]  Sid Gilman,et al.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. , 2009, Archives of neurology.

[26]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[27]  Günther Deuschl,et al.  Red flags for multiple system atrophy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[28]  Francesco Fera,et al.  Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. , 2006, Brain : a journal of neurology.

[29]  J. Cummings,et al.  Multiple system atrophy presenting with language impairment , 2006, Neurology.

[30]  P. Sandroni,et al.  Blood pressure recovery from Valsalva maneuver in patients with autonomic failure , 2005, Neurology.

[31]  G. Ebersbach,et al.  Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[32]  Niall P Quinn,et al.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.

[33]  Yoav Ben-Shlomo,et al.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. , 2002, Brain : a journal of neurology.

[34]  R. Sakakibara,et al.  Videourodynamic and sphincter motor unit potential analyses in Parkinson's disease and multiple system atrophy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[35]  N P Quinn,et al.  What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[36]  Irene Litvan,et al.  Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study , 1999, Journal of neurology, neurosurgery, and psychiatry.

[37]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[38]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[39]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.